BiotechTube
Home/Telix Pharmaceuticals Limited/Dr. Christian Behrenbruch
DC

Dr. Christian Behrenbruch

Managing Director and Group Chief Executive Officer

Telix Pharmaceuticals Limited

Roles

Managing Director and Group Chief Executive OfficeratTelix Pharmaceuticals Limited
Managing Director & Group Chief Executive OfficeratTelix Pharmaceuticals

Therapeutic Areas

OncologyUrologic CancerRenal CancerBrain Cancer

Telix Pharmaceuticals Limited Pipeline

DrugIndicationPhase
Illuccix® (TLX591-CDx)Prostate Cancer Imaging (PSMA-positive)Approved
TLX591Metastatic Castration-Resistant Prostate Cancer (mCRPC)Phase 3
TLX250-CDxClear Cell Renal Cell Carcinoma (ccRCC) ImagingPhase 3
TLX250Clear Cell Renal Cell Carcinoma (ccRCC) TherapyPhase 1
TLX101-CDxGlioblastoma ImagingPhase 3
TLX101Glioblastoma TherapyPhase 1
TLX592Prostate Cancer (Next-gen Alpha Therapy)Pre-clinical
TLX301CD20+ Hematologic MalignanciesPhase 1b

Leadership Team at Telix Pharmaceuticals Limited

MD
Mr. David C. (Dave) Marek
Chief Commercial Officer
DK
Dr. Kevin (Kevan) Richardson
Chief Operating Officer
MR
Mr. Richard G. Vale
Chief Financial Officer
DD
Dr. David (Dave) N. Cade
Chief Medical Officer
DM
Dr. Michael (Mick) J. McCahon
Chief Scientific Officer
MG
Ms. Gillian M. Wright
General Counsel and Company Secretary
DA
Dr. Andreas (Andi) Klug
Senior Vice President, Head of Europe
MR
Mr. Ryuichi (Roy) Mizuno
Senior Vice President, Head of Japan & Asia Pacific
MA
Mr. Andrew (Andy) M. Killingsworth
Non-Executive Chairman
DD
Dr. Diana (Dee) L. Holdsworth
Non-Executive Director
View full Telix Pharmaceuticals Limited profile